Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,047 | 60,855 | 65,688 | 74,315 | 80,240 |
| TOTAL | $55,697 | $62,201 | $67,439 | $75,225 | $81,689 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 15,200 | 15,200 | 15,200 |
| Intangibles | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 |
| Other Non-Current Assets | 51 | 51 | 51 | 30 | 74 |
| TOTAL | $14,921 | $14,921 | $30,121 | $30,099 | $30,143 |
| Total Assets | $70,618 | $77,122 | $97,559 | $105,325 | $111,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,586 | 1,853 | 1,201 | 1,594 | 1,130 |
| Accrued Expenses | 1,662 | 966 | 1,882 | 2,834 | 2,165 |
| TOTAL | $3,248 | $2,819 | $3,083 | $4,444 | $3,359 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 68,106 | 66,327 | 64,595 | 62,908 | 61,296 |
| TOTAL | $68,106 | $66,327 | $66,398 | $64,711 | $63,100 |
| Total Liabilities | $71,354 | $69,146 | $69,481 | $69,156 | $66,458 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,340 | 5,340 | 5,340 | 5,340 | 5,340 |
| Common Shares | 4 | 1 | 4 | 4 | 4 |
| Retained earnings | -344,466 | -334,701 | -313,395 | -304,189 | -293,600 |
| TOTAL | $-736 | $7,976 | $28,078 | $36,169 | $45,374 |
| Total Liabilities And Equity | $70,618 | $77,122 | $97,559 | $105,325 | $111,832 |